Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik's artificial intelligence-based TARIO-2 model identified spatial tumor ...
Everyday Health on MSN
Understanding Your Glioblastoma Pathology Report
Your pathology report includes vital information about your brain tumor that can guide treatment. Get to know how to interpret common terms.
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
Earlier this year, Paige raised the curtain and spotlighted new artificial intelligence models for digital cancer pathology. Now, the company is offering a peek behind the curtain by making versions ...
It’s where they raised two children, built deep connections through their local church, and spent countless weekends ...
The All India Institute of Medical Sciences (AIIMS), New Delhi, and the Centre for Development of Advanced Computing (C-DAC) ...
A new study suggests that Resmetirom may do more than treat fatty liver disease — it could also help stop liver cancer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results